- Investigator
- Mehdi S Mirsaeidi
- Ages
- 18 Years - 85 Years
- Sexes
- All
Clinical trials
-
A Study of the Efficacy and Safety of Treatment With MNKD-101 When Added to GBT in Participants with Pulmonary Nontuberculous Mycobacterial Infection -
A multicenter randomized controlled trial to establish the impact of MeMed BV簧 on management of patients with suspected Lower Respiratory Tract Infections - Investigator
- Phyllis L Hendry
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
Precision Cancer Survivorship Cohort - Ages
- 18 Years - N/A
- Sexes
- All
-
Access BNP Assay Clinical Subject Sample Collection Enrollment Study Protocol - Investigators
- Christine N Gage, Phyllis L Hendry
- Ages
- 22 Years - 100 Years
- Sexes
- All
-
DAPA-HF ACT - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) - Investigator
- Michael D Schweitzer Barrios
- Ages
- 40 Years - 80 Years
- Sexes
- All
-
Double Blind Placebo-Controlled Parallel Group Study of Safety and Efficacy of Isomyosamine in Treating Sarcopenia After Hip or Femoral Fracture in Gerontological Population - Investigator
- Porter F Young
- Ages
- 60 Years - 85 Years
- Sexes
- All
-
Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia - Investigator
- Mohammad Ilyas
- Ages
- 0 Years - 12 Years
- Sexes
- All